Firefly Neuroscience vs Kanso Diagnostics
Firefly Neuroscience vs Kanso Diagnostics, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Firefly Neuroscience is on 56/100 and Kanso Diagnostics on 53/100.
Where each one leads
Firefly Neuroscience
- our overall score: 56/100 against 53/100
- agent readiness: 49/100 against 28/100
- domain rating: 38/100 against 1/100
- headcount: 25 against 7
- funding raised: $45.4M against $1.8M
- LinkedIn following: 8,237 against 778
Kanso Diagnostics
- headcount growth: +22.1% against -3.3%
At a glance
| Measure | Firefly Neuroscience | Kanso Diagnostics |
|---|---|---|
| What it is | Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology. | Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need. |
| Category | Healthcare, Neurology, Mental Health, Brain EEG Injury | Healthcare, Diagnostics, Genetics, Pathology |
| Sells toBusiness model | B2B | B2B |
| Offering | Software, Hardware | Platform |
| Founded | 2006 | 2021 |
| Headquarters | San Francisco, United States | Or Yehuda, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Firefly Neuroscience | Kanso Diagnostics |
|---|---|---|
| Employees | 25 | 7 |
| Headcount growthLast 12 months | -3.3% | +22.1% |
| Total funding | $45.4M | $1.8M |
| Latest round | Series C | Seed |
| LinkedIn followers | 8,237 | 778 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Firefly Neuroscience | Kanso Diagnostics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 53/100 |
| Traction | 52/100 | 40/100 |
| Team | 50/100 | 70/100 |
| Community | 8/100 | 8/100 |
| Search visibility | 25/100 | 39/100 |
| Quality | 62/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (49/100) | F (28/100) |
| Domain ratingLink authority, 0-100 | 38/100 | 1/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Firefly Neuroscience | Kanso Diagnostics |
|---|---|---|
| Hosting | AWS | Netlify |
| CDN | Not detected | Netlify |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4, Google Tag Manager | Not detected |
| Support stack | HubSpot | Not detected |
Firefly Neuroscience vs Kanso Diagnostics: common questions
Which is better, Firefly Neuroscience or Kanso Diagnostics?
On our 0-100 score Firefly Neuroscience rates higher (56/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Firefly Neuroscience and Kanso Diagnostics compare on the numbers?
Firefly Neuroscience leads on our overall score (56/100 against 53/100), agent readiness (49/100 against 28/100), domain rating (38/100 against 1/100), headcount (25 against 7), funding raised ($45.4M against $1.8M), LinkedIn following (8,237 against 778). Kanso Diagnostics leads on headcount growth (+22.1% against -3.3%).
Read the full Firefly Neuroscience review and pricing or the Kanso Diagnostics review and pricing. You can also browse other Firefly Neuroscience alternatives we track.